Valuation Astal Laboratories Limited

Stocks

Market Closed - Bombay S.E. 06:02:31 2026-10-01 EDT			5-day change	1st Jan Change
69.54 ^INR	-1.93%		-0.66%	-19.93%

08-14	Astal Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-30	Astal Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	34.77	64.34	118.1	401.9	747.2	2,759
Change	-	85.03%	83.54%	240.29%	85.93%	269.28%
Enterprise Value (EV) ¹	34.46	64.16	117.2	344.2	862.6	3,251
Change	-	86.18%	82.75%	193.57%	150.59%	276.91%
P/E	577x	-376x	722x	26.3x	9.45x	8.37x
PBR	0.67x	1.25x	2.27x	1.72x	2.08x	0.83x
PEG	-	1x	-4x	0x	0x	-2.89x
Capitalization / Revenue	17.2x	30.5x	3.27x	1.7x	1.17x	1.11x
EV / Revenue	17.1x	30.4x	3.25x	1.45x	1.36x	1.31x
EV / EBITDA	-	-	-	-	-	-
EV / EBIT	-	-	-	-	-	-
EV / FCF	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	0.0152	-0.0431	0.041	1.554	8.043	7.81
Distribution rate	-	-	-	-	-	-
Net sales ¹	2.019	2.108	36.07	236.6	636.6	2,486
EBITDA	-	-	-	-	-	-
EBIT	-	-	-	-	-	-
Net income ¹	0.0602	-0.1711	0.164	7.847	89.25	147.1
Net Debt ¹	-0.3129	-0.1828	-0.844	-57.64	115.4	491.9
Reference price ²	8.75	16.19	29.60	40.88	76.01	65.36
Nbr of stocks (in thousands)	3,974	3,974	3,990	9,830	9,830	42,216
Announcement Date	9/1/21	9/8/22	8/25/23	7/12/24	8/18/25	9/7/26

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ASTAL LABORATORIES LIMITED	-	-	-	-	31.63M
ELI LILLY AND COMPANY	32.69x	11.85x	24.08x	0.6%	1,025B
JOHNSON & JOHNSON	28.77x	6.4x	17.91x	2.06%	623B
ABBVIE INC.	32.89x	7.71x	15.93x	2.67%	459B
MERCK & CO., INC.	104.62x	5.85x	24.82x	2.37%	355B
ROCHE HOLDING AG	18.99x	4.63x	11.47x	2.87%	336B
NOVARTIS AG	20.13x	5.23x	12.95x	3.06%	270B
ASTRAZENECA PLC	20.27x	4.21x	12x	2.1%	247B
AMGEN INC.	25.72x	6.72x	11.97x	2.48%	220B
GILEAD SCIENCES, INC.	-44.61x	6.5x	25.4x	2.23%	183B
Average	26.61x	6.57x	17.39x	2.27%	371.83B
Weighted average by Cap.	31.73x	7.64x	18.71x	1.95%